Most Recent Discussions

Sep 25 2020

Re: Rocklatan FDA Approved

Curious, I just started a patient (my first with this therapy) on Rocklatan after getting ZERO IOP change on generic Xalatan. He has been using it correctly for no more than two weeks but is complaining of bloodshot eyes. Is
read more

Jul 10 2018

Re: Longitudinal Study of Corneal Hysteresis

Great article, Jim, thanks.

Nov 27 2017

Re:

Clinician Topics

Glaucoma Watch: Interesting Glaucoma Cases; From Ocular Hypertension to Glaucoma: How to Predict Conversion; Neckties and IOP: The Controversy Continues; Introduction to the National Glaucoma Society; Case Presentation: Optic Nerve Imaging; NGS Residency Award and Lecture; Optic Nerve Head Measurements with the HRT III; Case Presentation: Laser Imaging Detects Early ON Damage; Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?; Interview with Dr. Barry Barresi; Glaucoma Continuum; Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study; The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older; Altered Nitric Oxide System in Patients with Open-Angle Glaucoma; Oxidative Stress in Glaucoma: A Burden of Evidence; Gonioscopy Videos; Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women; Programs to Optimize Adherence in Glaucoma; Corneal Hysteresis; Visual Field Interpretation; Study Questions link between Glaucoma and Alzheimer's Disease; Checking Color Vision; IOP Asymmetry as Glaucoma Risk Factor; Glaucoma Risk Calculators; Dr. David Calkins Discusses Catalyst for A Cure; Smart Phone Biosensor; Handheld OCT; Sustained Release IOP Therapies; Introduction to Corneal Hysteresis; FDT Perimetry; Visual Fields Overview; National Glaucoma Symposium 2017; Gonioscopy Slides from 2017 National Glaucoma Symposium; Measuring Corneal Hysteresis; XEN Glaucoma Implant Video; Corneal Hysteresis; Glaucoma Quality of Life Measures; Corneal Hysteresis: The A1C of Glaucoma; Predicting Progression; New Developments in Glaucoma Management; Longitudinal Study of Corneal Hysteresis; National Glaucoma Symposium 2018; DREAM Study; OIS at SECO; National Glaucoma Symposium Cape Cod; Is Glaucoma a Two-Pressure Disease?; ICD Stage Definitions; Visual Fields and Progression; OCT: The Basics; Co-Managing Glaucoma Surgery; Normal Tension Glaucoma; The Importance of Visual Fields; Corneal Hysteresis; Using OCT in Glaucoma Management; The LiGHT Study; Durysta Overview; Options in Glaucoma Surgery; Telemedicine in Glaucoma; Glaucoma Medications; New Visual Field Primer; Glaucoma Risk Factors; Drug Therapy for the Ocular Surface in Glaucoma; OCT Overview and Applications; Yoga as Adjunct Glaucoma Therapy; Cataract Surgery May Lower Risk for Dementia; Parapapillary Atrophy; Angle Closure Glaucoma; Congratulations to Dr. Thimons

In Your Office: Glaucoma Flowsheet; Tonometer Calibration; Pachymetry Coding; BCBS Coverage of SCODI Services; Expanded Coverage of Glaucoma Screening Services; Coding Update: 92135 Deleted and Replaced; ABO Certification Review Materials; Small Fee Reduction in CMS Payments in 2015; Moist Heat Compresses; Information about Omega-3s; Glaucoma Website for Patients; Beware of Phone Scam Posing as DPH or DEA; Tonography; Patient Assistance Programs; Plaquenil Reporting Form; World Optometry Day

Pharmacology Update: Extravan: Alcon Pharmaceuticals; Mechanism of IOP Reduction with Travoprost; Hydroxychloroquine Toxicity; Timolol; Upneeq Drops for Ptosis; Tetracaine Study

Clinical Guidelines: CCT: Is is time to say YES?; The Role of CCT in Glaucoma Patients; More CCT; The Paradox of IOP; Should We Treat All Ocular Hypertensives?; Beta Blockers in Glaucoma Management; Re-Defining Ocular Hypertension; Implications of Macro-Disc Asymmetry in Glaucoma Suspects; Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies; CyPass Clinical Recommendations; Optic Disc Cupping and Neuroimaging

Industry News: New FDA Approval for Lumigan; Alcon's Travatan Z Solution Receives FDA Approval; Alcon's Travatan Z and Systane Use Different Preservatives; Pfizer Sponsors New "All Eyes on Glaucoma" Website; CLIA Waivers; Bausch + Lomb New Glaucoma Drug; Glaukos iStent inject FDA Approved; Alcon Withdraws CyPass Stents; Nuretin Omega-3 Supplements; Rocklatan FDA Approved; Vivid Vision Perimetry; Falck Multifunction Device; Zeiss Medical Device Recall; Sustained IOP Reduction with iDose TR

Upcoming Programs

October 12, 2022

Dr. Eric Schmidt will present "Roadmap for the Medical Management of Glaucoma" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific).

October 19, 2022

Dr. Brad Sutton will present "Taking the Mystery Out of Oral Medications" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific).

November 2, 2022

Dr. Mitch Ibach will present "Perimetry Primer: Fundamentals of Visual Fields" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific).

November 16, 2022

Dr. Nate Lighthizer will present "Floaters: A New Solution to an Old Problem" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific).

November 30, 2022

Dr. Danica Marrelli will present "Strategies for Better Diagnosis of Glaucoma" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific).

December 7, 2022

For the last webinar of 2022, Dr. Daniel Epshtein will present "Glaucoma Masqueraders" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific).

Your Registrations

You have no registrations currently in your cart.

News

COPE RULES FOR INTERACTIVE WEBINARS 2023

COPE will institute new regulations in January 2023 that treat interactive webinars in the same category as in-person lectures. CE will be categorized as either synchronous (lecturer and learner are together at the same time, either in-person or virtually, with real-time communication) or asynchronous (lecturer and learner are not together at same time, no real-time communication). Please Note: State Boards may still restrict the number of synchronous virtual hours of CE allowed for license renewal.

NGS WEBINARS

The interactive NGS webinars will continue twice a month from January-May 2023. Speakers and topics will be posted soon.

NGS MEMBERSHIP

As we plan NGS activities beyond May 2023, we are suspending the option for annual Full membership for both new membership and renewals and will offer only 6-month membership starting October 17.

LIVE WEBINARS = LIVE CE IN MASSACHUSETTS

At their Decmber 15, 2021 meeting, the Massachusetts Board of Optometry specified that a live webinar where speakers and attendees can interact in real-time are considered to be live CE. The Board clarified that distance learning CE courses, which are limited to 6 hours per renewal cycle, are those where the licensees are reading content or observing media on their own with no interaction with the instructor. Thus, the COPE-approved interactive NGS webinars count as live CE for MA optometrists.

NEW HAMPSHIRE ALLOWS 100% VIRTUAL CE IN 2022

The New Hampshire Board of Optometry has issued has a new standing order dated January 11, 2022 that authorizes all credit hours of continuing education to be obtained through virtual or alternative means in 2022. A copy of this order can be found on the New Hampshire Board of Optometry website (oplc.nh.gov) under Laws and Rules.

CE BROKER FOR TEXAS OPTOMETRISTS

The NGS will submit attendance data to CE Broker for Texas optometrists who attend our webinars. We will continue to mail CE certificates so attendees have a copy for their records and also will send attendance data to ARBO's OE Tracker.

PENNSYLVANIA CONTINUES TO ALLOW ONLINE CE

The NGS has just been notified that the Board of Optometry will continue to allow all CE to be online for the renewal period that ends November 30. 2022. There was communication that the waiver in Pennsylvania that allowed all CE to be virtual will end on September 30, 2021. However, to avoid confusion in the middle of the renewal cycle, the Board has decided to continue to allow all CE to be online.

CALIFORNIA ALLOWS LIVE WEBINARS AS LIVE CE

The California Board of Optometry now recognizes interactive courses offered live over internet platforms such as WebEx as Live CE toward the 30 hours of live continuing education required for license renewal. Courses can be live COPE courses offered by COPE's June 30, 2021 deadline or courses approved by the Board.

NGS LIVE WEBINARS = CATEGORY 1 ABO

We have received confirmation that the NGS live webinars now count as Category 1 Education towards American Board of Optometry (ABO) certification.

Join Our Email List

National Glaucoma Society